Global Cell Banking Outsourcing Market, By Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking), Product (Cord Cell Banking, Adult Stem Cell Banking, Induced Pluripotent Stem Cell Banking, Embryonic Stem Cell Banking), Cell Type (Stem Cell, Non-Stem Cell), Phase (Bank Storage, Cell Storage Stability Testing, Bank Preparation, Bank Characterization and Testing) – Industry Trends and Forecast to 2029.
Cell Banking Outsourcing Market Analysis and Size
The process of storing cells for future use is known as cell banking. These cell samples can be kept indefinitely for research purposes and surgical tissue regeneration. To freeze cells in cryovials at -196 degrees Celsius, cryoprotection agents such as DMSO (10%) solution are used. Cell banking is most commonly used in stem cell research and therapy. There are two types of cell banks: master cell banks and operational cell banks. Working cell banks are created by expanding master cell banks. Working cell banks have thawed cells that are replicated in cell culture, whereas master cell banks have pure cells from which cells are replicated.
Data Bridge Market Research analyses that the cell banking outsourcing market which was USD 9,204.22 million in 2021, is expected to reach USD 26,440.65 million by 2029, at a CAGR of 14.1% during the forecast period 2022 to 2029. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Cell Banking Outsourcing Market Scope and Segmentation
2022 to 2029
2020 (Customizable to 2014 - 2019)
Revenue in USD Million, Volumes in Units, Pricing in USD
Type (Master Cell Banking, Viral Cell Banking, Working Cell Banking), Product (Cord Cell Banking, Adult Stem Cell Banking, IPS Stem Cell Banking, Embryonic Stem Cell Banking,), Cell Type (Stem Cell, Non-Stem Cell), Phase (Bank Storage, Cell Storage Stability Testing, Bank Preparation, Bank Characterization and Testing)
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Market Players Covered
Sigma-Aldrich Co. LLC. (U.S.), Sartorius AG (Germany), BSL Bioservice (Germany), Charles River Laboratories. (U.S.), Labcorp Drug Development (U.S.), Lonza (Switzerland), SGS Société Générale de Surveillance SA (Switzerland), Toxikon Corp. (U.S.), WuXi AppTec (China), Reliance Life Sciences (India), LifeCell International Pvt. Ltd. (India), Cryoviva India (India), Cordlife (Singapore), Texcell (France), Goodwin Biotechnology Inc. (U.S.), Transcell Biolife Pvt ltd (India), Cryo-Cell (U.S.), Stem Cells Group (U.S.)
A cell bank is a type of facility that stores cells derived from various body fluids and organ tissue for future use. The cells are stored with detailed characterization of the cell line, which reduces the possibility of cross-contamination. Storage, collection, characterization, and testing of cells, cell lines, and tissues are all part of the cell banking outsourcing industry. Cell banks provide cell lines, cells, and tissues for research and development, as well as biopharmaceutical production with maximum efficacy and minimal adverse events.
Global Cell Banking Outsourcing Market Dynamics
- Rising adoption of cellular products
The rising adoption of cellular products for research and development, combined with the high prevalence of diseases, is expected to accelerate the growth rate of the global cell banking outsourcing market. There were approximately one million hematopoietic stem cell transplants between 2006 and 2014, according to a World Blood and Marrow Transplant Network survey. These included peripheral blood cells, as well as their proliferation and storage in cell banks for later use in patients. Furthermore, the growing demand for biologics such as vaccines, which require the use of viral cell banking, has resulted in the global cell banking outsourcing market expanding positively.
- Increased number of government initiative to bolster the growth
The presence of favourable government initiatives for the development of stable cell lines, as well as the introduction of new technology for cell line storage and characterization, are among the critical factors expected to drive market growth during the forecast period. For instance, in December 2021, 'Vineti' and 'Be The Match BioTherapies' collaborated to develop an integrated supply chain management solution for gene and cell therapy. Such initiatives and collaborations are expected to drive growth during the forecast period.
- Rising usage of stem cell transplantation procedures
According to a World Network for Blood and Marrow Transplantation (WBMN) survey, nearly 1 million hematopoietic stem cell transplantation procedures were performed between 2006 and 2014. These procedures included removing stem cells from peripheral blood or bone marrow, proliferating them and finally storing them in cell banks for future use by patients. Stem cell therapies have the potential to treat a wide range of diseases, including amyotrophic lateral sclerosis, type 1 diabetes, cancer, Alzheimer's disease, Parkinson's disease, and others. The ability to cure a wide range of diseases is expected to drive growth in the global cell banking outsourcing market in the coming years.
- High cost of storing cells will challenge the growth
The high cost of storing the cells in cell banks is a significant challenge for this market. Furthermore, there are some legal issues associated with the storage of various cells, particularly stem cells, which are expected to limit market growth. Finally, one of the risks associated with cell banking is cell contamination due to human error or environmental conditions, so caution should be exercised when storing and handling cells.
This cell banking outsourcing market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the cell banking outsourcing market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Cell Banking Outsourcing Market
According to CellTrials.org, global enrolment in new advanced cell therapy trials increased by nearly 30% in the first quarter of 2020. The majority of the increase can be attributed to cell therapy efforts for COVID-19 treatment, with umbilical cord MSCs being used in more than half of those trials. As a result, the pandemic has created a new market for companies engaged in the manufacturing of MSCs products from donated birth tissues, which may contribute to market growth following the pandemic. During the forecast period, the increasing prevalence of COVID-19 is expected to cause significant changes in global cell banking outsourcing. In addition, as the coronavirus outbreak continues, many regional markets have suffered significant losses, negatively impacting the cellular banking outsourcing market.
- In September 2021, Life Cell's Mesocel received DCGI approval for a clinical trial therapy derived MSC from umbilical cord tissue set to treat patients with pneumonia, COVID-19, and acute respiratory distress.
- In December 2021, 'Vineti' and 'Be The Match BioTherapies' will collaborate to develop an integrated supply chain management solution for gene and cell therapy. During the forecast period, such initiatives and collaborations are expected to drive growth.
Global Cell Banking Outsourcing Market Scope
The cell banking outsourcing market is segmented on the basis of type, product, cell type and phase. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Master Cell Banking
- Working Cell Banking
- Viral Cell Banking
- Stem Cell
- Cord Cell Banking
- Embryonic Stem Cell Banking
- Adult Stem Cell Banking
- Dental Stem Cell Banking
- Induced Pluripotent Stem Cell Banking
- Non-stem Cell
- Bank Storage
- Master Cell Bank Storage
- Working Cell Bank Storage
- Cell Storage Stability Testing
- Bank Characterization and Testing
- Safety Testing
- Viral Cell Banks
- Microbial Cell Banks
- Gene Expression Testing
- Karyology Testing
- Gene Sequencing Testing
- Bank Preparation
- Master Cell Bank Preparation
- Working Cell Bank Preparation
- Cell Storage Stability Testing
Cell Banking Outsourcing Market Regional Analysis/Insights
The cell banking outsourcing market is analysed and market size insights and trends are provided by country, type, product, cell type and phase as referenced above.
The countries covered in the cell banking outsourcing market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the cell banking outsourcing market due to the increasing production of vaccines, antibiotics and therapeutic proteins and availability of biopharmaceutical manufacturers. owing to the presence of extensive R&D laboratories and rising incidences of metabolic disorders such as Parkinson’s, Alzheimer’s, and various other types of cancers, which can be treated by gene therapy.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 This exponential CAGR is credited to the presence of pharmaceutical companies, which are focusing their priorities on the large and relatively untapped populations in Asia.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The cell banking outsourcing market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for cell banking outsourcing market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the cell banking outsourcing market. The data is available for historic period 2010-2020.
Competitive Landscape and Cell Banking Outsourcing Market Share Analysis
The cell banking outsourcing market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to cell banking outsourcing market.
Some of the major players operating in the cell banking outsourcing market are:
- Sigma-Aldrich Co. LLC. (U.S.)
- Sartorius AG (Germany)
- BSL Bioservice (Germany)
- Charles River Laboratories. (U.S.)
- Labcorp Drug Development (U.S.)
- Lonza (Switzerland)
- SGS Société Générale de Surveillance SA (Switzerland)
- Toxikon Corp. (U.S.)
- WuXi AppTec (China)
- Reliance Life Sciences (India)
- LifeCell International Pvt. Ltd. (India)
- Cryoviva India (India)
- Cordlife (Singapore)
- Texcell (France)
- Goodwin Biotechnology Inc. (U.S.)
- Transcell Biolife Pvt ltd (India)
- Cryo-Cell (U.S.)
- Stem Cells Group (U.S.)